Role of Interferon-gamma Release Assay for Screening and Monitoring of Latent Tuberculosis Infection in Kidney Transplant Recipients

Phase 3

Completed

• Conditions: Adult kidney transplant recipients; TB, isoniazid, immunocompromised

• Registration Number: TCTR20220720008
• Lead Sponsor: Faculty of Medicine Ramathibodi Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2021-08-31
• Study Start: 2022-07-20
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

All adult kidney transplant recipients

Exclusion Criteria

those who are not willing to participate

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
TB-specific immunity 9 months T.SPOT-TB

Secondary Outcome Measures

Name	Time	Method
TB 9 months PCR